Correspondence to Professor Peter Brown, Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK; peter.brown{at}ndcn.ox.ac ...
Background The MIND diet was favourably linked to lower risk of neurodegenerative diseases. While previous cross-sectional studies implied its beneficial associations with brain imaging markers, its ...
1 Severe Epilepsies Outpatient Clinic, Neurology Service, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil 2 Porto Alegre Epilepsy Surgery ...
1 Ningbo Kangning Hospital, Ningbo, Zhejiang, People's Republic of China 2 Guangdong Key Laboratory of Non-human Primate Research, Guangdong-Hong Kong-Macau Institute of CNS Regeneration, Jinan ...
Objectives To evaluate the ability of tacrolimus to reduce the corticosteroid dose in patients with myasthenia gravis (MG) and the drug's safety in a double-blind, placebo-controlled, parallel group ...
Methods The MEDLINE, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, ClinicalTrials.gov and the WHO’s International Clinical Trials Registry Platform search portal were searched from ...
1 Department of Psychiatry, ARKIN Mental Health Care, Amsterdam, The Netherlands 2 Department of Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands 3 EMGO institute LASA, VU ...
Background Functional movement disorder (FMD) is a common cause of debilitating symptoms in neurology patients. Due to the stigma that is associated with FMD, it is possible that discrepancies between ...
Objectives The risk of recurrence following a first-ever seizure is 40–50%, warranting driving restriction during the early period of highest risk. This restriction must be balanced against the ...
Background In multiple sclerosis (MS), disability accrual can arise from relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA). While genetic variants associated ...
Background Small fibre neuropathy (SFN) affects small myelinated Aδ- and unmyelinated C-fibres and causes neuropathic pain and autonomic symptoms. Earlier Dutch estimates, over a decade old, reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results